Ocular Therapeutix completes pre-NDA meeting with FDA for wet AMD drug
Ocular Therapeutix, Inc. (NASDAQ: OCUL) announced the completion of a Pre-New Drug Application (NDA) meeting with the U.S. Food and ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)